| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.37 | 0.0004 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |